Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Rosa Polo Rodríguez, María José Galindo Puerto, Carlos Dueñas, Carmen Gómez Candela, Vicente Estrada, Noemí G.P. Villar, Jaime Locutura, Ana Mariño, Javier Pascua, Rosario Palacios, Miguel Ángel Von Wichmman, Julia Álvarez, Victor Asensi, José Lopez Aldeguer, Fernando Lozano, Eugenia Negredo, Enrique Ortega, Enric Pedrol, Félix Gutiérrez, Jesús Sanz SanzEsteban Martínez Chamorro

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

© 2014 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.
Original languageEnglish
Pages (from-to)41-47
JournalEnfermedades Infecciosas y Microbiologia Clinica
Volume33
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • Cardiovascular risk
  • HIV infection
  • Metabolic disorders

Fingerprint Dive into the research topics of 'Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection'. Together they form a unique fingerprint.

Cite this